Max Dale Cooper

Max D. Cooper, M.D., Professor of Pathology and Laboratory Medicine, is a Georgia Research Alliance Eminent Scholar and member of the Vaccine Center at the Emory University School of Medicine. His laboratory currently studies the evolution of adaptive immunity and explores the use of lamprey monoclonal antibodies for diagnosis and therapy of infectious diseases and lymphoid malignancies in humans. Cooper worked with Robert Good to define the independent development of the functionally-interactive T and B cell lineages, with Paul Kincade to discover antibody class switching by B cells, Dale Bockman to describe the lymphoid follicle-associated epithelial “M” cells in the intestine and their transcytotic function, and with Martin Raff and John Owen to define the fetal liver and bone marrow origin of B cells and pre-B cells. He is a member of the U.S. National Academy of Sciences, the Academy of Medicine, the American Academy of Arts and Sciences, a foreign member of the French Academy of Sciences and the Royal Society of London.  Cooper is a former president of the American Association of Immunologists, the Clinical Immunology Society and the Kunkel Society. Honors include the Society for Experimental Biology and Medicine Founder’s Award, Sandoz Prize in Immunology, American College of Physicians Science Award, American Association of Immunologists (AAI) Lifetime Achievement Award, AAI-Dana Foundation Award in Human Immunology Research, Avery-Landsteiner Prize, the Robert Koch Prize, AAI Excellence in Mentoring Award and the Japan Prize.